These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3970812)

  • 41. Caryometry and nuclear ultrastructure of cultured human breast cancer cells (FAM) after oestradiol administration.
    Gay G; Jozan S; Marquès B; David JF
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1985; 48(1):47-57. PubMed ID: 2858938
    [TBL] [Abstract][Full Text] [Related]  

  • 42. 17 beta-estradiol-regulated expression of protein tyrosine phosphatase gamma gene in cultured human normal breast and breast cancer cells.
    Zheng J; Kulp SK; Zhang Y; Sugimoto Y; Dayton MA; Govindan MV; Brueggemeier RW; Lin YC
    Anticancer Res; 2000; 20(1A):11-9. PubMed ID: 10769629
    [TBL] [Abstract][Full Text] [Related]  

  • 43. H-ras dependent estrogenic effects of epidermal growth factor in the estrogen-independent breast cancer cell line MDA-MB-231.
    Treeck O; Weber A; Boester M; Porz S; Frey N; Diedrich K; Ortmann O
    Breast Cancer Res Treat; 2003 Jul; 80(2):155-62. PubMed ID: 12908818
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Estrogen deprivation causes estradiol hypersensitivity in human breast cancer cells.
    Masamura S; Santner SJ; Heitjan DF; Santen RJ
    J Clin Endocrinol Metab; 1995 Oct; 80(10):2918-25. PubMed ID: 7559875
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of 4-hydroxytamoxifen and a novel pure antioestrogen (ICI 182780) on the clonogenic growth of human breast cancer cells in vitro.
    DeFriend DJ; Anderson E; Bell J; Wilks DP; West CM; Mansel RE; Howell A
    Br J Cancer; 1994 Aug; 70(2):204-11. PubMed ID: 8054267
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Receptors for EGF and oestradiol and thymidinekinase activity in different histological subgroups of human mammary carcinomas.
    Skoog L; Macias A; Azavedo E; Lombardero J; Klintenberg C
    Br J Cancer; 1986 Aug; 54(2):271-6. PubMed ID: 3017397
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antiestrogenic effects of Z-1, 1-dichloro-2,3 diphenyl-2-(4-methoxyphenyl)cyclopropane(5a) on human breast cancer cells in culture.
    Jain PT; Pento JT; Magarian RA
    Anticancer Res; 1992; 12(3):585-90. PubMed ID: 1622114
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Steroid-free medium discloses oestrogenic effects of the bisphosphonate clodronate on breast cancer cells.
    Journe F; Chaboteaux C; Dumon JC; Leclercq G; Laurent G; Body JJ
    Br J Cancer; 2004 Nov; 91(9):1703-10. PubMed ID: 15477866
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of statins combined with estradiol on the proliferation of human receptor-positive and receptor-negative breast cancer cells.
    Mueck AO; Seeger H; Wallwiener D
    Menopause; 2003; 10(4):332-6. PubMed ID: 12851516
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antitumor action of physiological estradiol on tamoxifen-stimulated breast tumors grown in athymic mice.
    Yao K; Lee ES; Bentrem DJ; England G; Schafer JI; O'Regan RM; Jordan VC
    Clin Cancer Res; 2000 May; 6(5):2028-36. PubMed ID: 10815929
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antiestrogen potentiation of antiproliferative effects of vitamin D3 analogues in breast cancer cells.
    Love-Schimenti CD; Gibson DF; Ratnam AV; Bikle DD
    Cancer Res; 1996 Jun; 56(12):2789-94. PubMed ID: 8665515
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of estrogen and tamoxifen on the regulation of dihydrofolate reductase gene expression in a human breast cancer cell line.
    Levine RM; Rubalcaba E; Lippman ME; Cowan KH
    Cancer Res; 1985 Apr; 45(4):1644-50. PubMed ID: 3978632
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Expression of transforming growth factor alpha antisense mRNA inhibits the estrogen-induced production of TGF alpha and estrogen-induced proliferation of estrogen-responsive human breast cancer cells.
    Kenney NJ; Saeki T; Gottardis M; Kim N; Garcia-Morales P; Martin MB; Normanno N; Ciardiello F; Day A; Cutler ML
    J Cell Physiol; 1993 Sep; 156(3):497-514. PubMed ID: 8360257
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Selective estrogen receptor modulators as inhibitors of repopulation of human breast cancer cell lines after chemotherapy.
    Licun W; Tannock IF
    Clin Cancer Res; 2003 Oct; 9(12):4614-8. PubMed ID: 14555537
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Estrogen regulates somatostatin receptor subtype 2 messenger ribonucleic acid expression in human breast cancer cells.
    Xu Y; Song J; Berelowitz M; Bruno JF
    Endocrinology; 1996 Dec; 137(12):5634-40. PubMed ID: 8940394
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Transforming growth factors type beta 1 and beta 2 are equipotent growth inhibitors of human breast cancer cell lines.
    Zugmaier G; Ennis BW; Deschauer B; Katz D; Knabbe C; Wilding G; Daly P; Lippman ME; Dickson RB
    J Cell Physiol; 1989 Nov; 141(2):353-61. PubMed ID: 2808542
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The oestrogen-like effect of 4-hydroxytamoxifen on induction of transforming growth factor alpha mRNA in MDA-MB-231 breast cancer cells stably expressing the oestrogen receptor.
    Levenson AS; Tonetti DA; Jordan VC
    Br J Cancer; 1998 Jun; 77(11):1812-9. PubMed ID: 9667651
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Modulation of the insulin-like growth factor-I system by N-(4-hydroxyphenyl)-retinamide in human breast cancer cell lines.
    Favoni RE; de Cupis A; Bruno S; Yee D; Ferrera A; Pirani P; Costa A; Decensi A
    Br J Cancer; 1998 Jun; 77(12):2138-47. PubMed ID: 9649125
    [TBL] [Abstract][Full Text] [Related]  

  • 59. 5-En-androstene-3 beta,17 beta-diol inhibits the growth of MCF-7 breast cancer cells when oestrogen receptors are blocked by oestradiol.
    Boccuzzi G; Brignardello E; Di Monaco M; Gatto V; Leonardi L; Pizzini A; Gallo M
    Br J Cancer; 1994 Dec; 70(6):1035-9. PubMed ID: 7981051
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Estrogenic actions of RU486 in hormone-responsive MCF-7 human breast cancer cells.
    Jeng MH; Langan-Fahey SM; Jordan VC
    Endocrinology; 1993 Jun; 132(6):2622-30. PubMed ID: 8504763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.